Potential Mechanisms of Guizhi Fuling Wan in Treating Endometriosis: An Analysis Based on TCMSP and DisGeNET Databases
review
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
Guizhi Fuling Wan may inhibit endometriosis by modulating immunity, apoptosis, and angiogenesis, potentially via AGE-RAGE, Kaposi sarcoma-associated herpesvirus, human cytomegalovirus, and fluid shear stress pathways.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Guizhi Fuling Wan (GFW), is a traditional Chinese herbal formula that consists of Cinnamomi Ramulus (Guizhi), Poria Cocos(Schw.) Wolf. (Fuling), Persicae Semen (Taoren), Radix Paeoniae Rubra (Chishao), and Cortex Moutan (Mudanpi). This formula has been used in traditional Chinese medicine for more than 1800 years to treat disorders caused by stagnation of circulation and qi (air).
AIM OF THE STUDY: Based on pre-clinical and clinical studies, this review aimed to reveal the potential mechanisms of GFW in inhibiting endometriosis. The enhancement of therapeutic effects of western medications on endometriosis by GFW was also shown.
MATERIALS AND METHODS: A bibliographic assessment of publications on "Guizhi Fuling Wan" and "endometriosis" indexed in PubMed, Science Direct, and China National Knowledge Infrastructure (CNKI) was conducted. Five pre-clinical studies and 13 clinical studies were selected for this review. Moreover, the targeted molecules of each herb were first extracted from the Traditional Chinese Medicine Systems Pharmacology (TCMSP) Database and Analysis Platform followed by obtaining the endometriosis-related genes from DisGeNET. Subsequently, pathway and gene ontology analyses using David Bioinformatics Resources explored the potential mechanisms of therapeutic effects of GFW in treating endometriosis.
RESULTS: Pre-clinical and clinical studies showed that GFW might inhibit the growth of endometriotic lesion through the modulation of immunity, apoptosis-regulating molecules, and angiogenesis-associated factors, while enhancing the therapeutic effects of western medications in treating endometriosis. Furthermore, pathway and gene ontology analyses demonstrated that GFW might attenuate the disease primarily by affecting AGE-RAGE signaling pathway in diabetic complications (hsa04933) as well as pathways involved in Kaposi sarcoma-associated herpesvirus infection (hsa05167), human cytomegalovirus infection (has05163), and fluid shear stress and atherosclerosis (hsa05418). These pathways were all involved in the regulation of inflammation, angiogenesis, and apoptosis and commonly affected by all herbs.
CONCLUSIONS: The current review revealed that endometriosis is highly associated with aberrant inflammatory, angiogenic, and apoptotic activities. The therapeutic effects of GFW on endometriosis are likely to act through regulating these activities.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (58)
- 17β-Estradiol and Lipopolysaccharide Additively Promote Pelvic Inflammation and Growth of Endometriosis via openalex
- Aberrant Expression of Leptin in Human Endometriotic Stromal Cells Is Induced by Elevated Levels of Hypoxia Inducible Factor-1α via openalex
- Ablation of Leptin Signaling Disrupts the Establishment, Development, and Maintenance of Endometriosis-Like Lesions in a Murine Model via openalex
- Apoptosis and endometriosis via openalex
- A Reassessment of the Therapeutic Potential of a Dopamine Receptor 2 Agonist (D2-AG) in Endometriosis by Comparison against a Standardized Antiangiogenic Treatment via openalex
- CD4+Foxp3+ regulatory T cell differentiation mediated by endometrial stromal cell-derived TECK promotes the growth and invasion of endometriotic lesions via openalex
- Combinatory effects of current regimens and Guizhi Fuling Wan on the development of endometriosis via openalex
- Effect of prenatal exposure to TCDD on the promotion of endometriotic lesion growth by TCDD in adult female rats and mice via openalex
- Effects of 17β‐estradiol on the release of monocyte chemotactic protein‐1 and MAPK activity in monocytes stimulated with peritoneal fluid from endometriosis patients via openalex
- Endometriosis via openalex
- Expression of Vascular Endothelial Growth Factor (VEGF), Hypoxia Inducible Factor-1α (HIF-1α), and Microvessel Density in Endometrial Tissue in Women With Adenomyosis via openalex
- Guizhi Fuling capsule, an ancient Chinese formula, attenuates endometriosis in rats via induction of apoptosis via openalex
- Hypoxia-Induced MicroRNA-20a Expression Increases ERK Phosphorylation and Angiogenic Gene Expression in Endometriotic Stromal Cells via openalex
- Identification of Altered Evoked and Non-Evoked Responses in a Heterologous Mouse Model of Endometriosis-Associated Pain via openalex
- Identifying Chinese Herbal Medicine Network for Endometriosis: Implications from a Population‐Based Database in Taiwan via openalex
- Immunobiology of endometriosis via openalex
- Immunological regulation of Chinese herb Guizhi Fuling Capsule on rat endometriosis model via openalex
- Inhibition of dual specificity phosphatase-2 by hypoxia promotes interleukin-8-mediated angiogenesis in endometriosis via openalex
- Interleukin‐22 secreted by ectopic endometrial stromal cells and natural killer cells promotes the recruitment of macrophages through promoting CCL2 secretion via openalex
- Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells via openalex
- Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis via openalex
- P-selectin as a potential therapeutic target for endometriosis via openalex
- Regression of endometrial explants in a rat model of endometriosis treated with melatonin via openalex
- Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Induces Apoptosis of Human Endometriotic Cells through Suppression of ERK1/2, AKT, NFκB, and β-Catenin Pathways and Activation of Intrinsic Apoptotic Mechanisms via openalex
- Survivin Gene Expression in Endometriosis via openalex
- The Differential Expression of Intercellular Adhesion Molecule‐1 (ICAM‐1) and Regulation by Interferon‐Gamma during the Pathogenesis of Endometriosis via openalex
- The high level of RANTES in the ectopic milieu recruits macrophages and induces their tolerance in progression of endometriosis via openalex
- The Traditional Chinese Medicine Prescription Pattern of Endometriosis Patients in Taiwan: A Population-Based Study via openalex
- Traditional Chinese medicine prescription Guizhi Fuling Pills in the treatment of endometriosis via openalex
- Understanding the Role of Gui‐Zhi‐Fu‐Ling‐Capsules (Chinese Medicine) for Treatment of Endometriosis in the Rat Model: Using NMR Based Metabolomics via openalex
- Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. via openalex
- W2119062775 via openalex
- W2068917566 via openalex
- W2124679671 via openalex
- W2146493861 via openalex
- W2058692557 via openalex
- W2155523608 via openalex
- W2161428126 via openalex
- W2025558388 via openalex
- W2165036434 via openalex
- W2168743965 via openalex
- W2219450326 via openalex
- W2538537547 via openalex
- W2019129059 via openalex
- W2006760151 via openalex
- W1985563073 via openalex
- W1985148363 via openalex
- W4200010084 via openalex
- W1977258127 via openalex
- W1966785366 via openalex
- W4234160457 via openalex
- W1966257589 via openalex
- W6759403193 via openalex
- W2087617912 via openalex
- W6845773978 via openalex
- W2096747133 via openalex
- W2087037893 via openalex
- W2082713633 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-08-21T06:14:13.963979+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-08-21T06:12:30.247066+00:00
- unpaywall
- last seen: 2026-08-21T06:37:11.537704+00:00
License: CC0
· commercial use OK